Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.

Genomic changes in the infectious yeast Candida tropicalis may play a role in its resistance to antifungals, according to a study published in PLOS Biology.The work, led by Guanghua Huang at Fudan ...

Between 2020 and 2021, the U.S. saw a 95 percent rise in clinical cases of infections with the yeast Candida auris, roughly a ...